Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-low Dose Transdermal Estradiol in Prepubertal Girls With Turner Syndrome and Primary Ovarian Insufficiency
NCT07784582Phase 2Not yet recruiting
- Sponsor
- Children's National Research Institute
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in Turner syndrome (TS), primary ovarian insufficiency (POI), sponsored by Children's National Research Institute. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
estradiol
03
Conditions
Turner syndrome (TS)primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07784582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07784582.